Christina Ackermann
Director · Verona Pharma plc
- 2024
- Oct 7, 2025
- 3
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Christina Ackermann. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Zaccardelli - $11.26M in VRNA purchases and sales on record
- Mark W. Hahn - $11.26M in VRNA purchases and sales on record
- Kathleen A. Rickard - $1.94M in VRNA purchases and sales on record
- David R. Ebsworth - $303K in VRNA purchases and sales on record
- Michael Austwick - $148K in VRNA purchases and sales on record
- Kenneth Cunningham - $142K in VRNA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christina Ackermann?
Christina Ackermann is a corporate insider, tracked as Director of Verona Pharma plc (VRNA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christina Ackermann last file a Form 4?
The most recent primary Form 4 on record is dated 7 October 2025, one of 3 filings going back to 2024.
Has Christina Ackermann been buying or selling stock?
Recorded transactions: 1 open-market purchase ($198K) and 1 open-market sale ($24K) across all tracked filings.
